hotspot -WSS

hotspot

author：entertainment 2025-08-19 18:02:41 - browse：68168

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： STAT Readout: Friday, Oct. 20 biotech updates

WSS

U.K. decision on ALS drug has neurologists, advocates up in arms

Bird flu in dairy cattle: New measures to control spread to humans

Why a market frenzy over new weight loss drugs defies logic

STAT Summit: The economic case for universal basic health care

STAT Summit: The economic case for universal basic health care

UnitedHealth, in a surprise, takes aim at Steward’s physician group

explore

hotspot

explore

Walensky prepares to leave CDC — and Congress — behind

Trial using CRISPR to edit HIV out of cells disappoints

Medical leaders decry Supreme Court decision on affirmative action

Why a market frenzy over new weight loss drugs defies logic

Hollywood unions extend contract negotiations for actors

People with mental disorders often marry others with same

Medical leaders decry Supreme Court decision on affirmative action

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Medical leaders decry Supreme Court decision on affirmative action

Bird flu in dairy cattle: New measures to control spread to humans

Wikipedia

Florida Supreme Court upholds state's abortion ban

FDA clears Verve to begin U.S. study of gene

Hundreds died while taking an arthritis drug, but nobody alerted patients

Study on Amgen’s bispecific immunotherapy produces positive data

Smaller biotechs seek to piggyback on weight loss drug boom

Overprescribed: High cost isn't America's only drug problem

focus

knowledge

hotspot

hotspot